Ems allows users to search out the right place to live through data and suggestions. Ems uses live data available on mobile, helping those looking to move to find out everything they need to know about any area in London whilst discovering new areas that perfectly match up with their own requirements.
days to go:
Expired
investment:
£115,600
Koble claims that its data-driven Software as a Service (SaaS) tool helps accelerators and incubators streamline their selection process so they can focus on the most promising founders. The company's vision is to price early-stage startup risk and reward. It intends to move from a Software as a Service (SaaS) workflow tool to the startup-investor marketplace. Koble asserts that pre-seed and seed investors lack a quantitative approach in the early stage of recognising promising startups. Koble argues that its approach is different; it claims that its algorithms are built to mimic the decision processes (both analytical and intuitive) that humans go through when analysing a startup. The tool collects structured, well-tagged data that is not available in the public domain and power the first algorithms that can predict startup success. The company envisages three exit options, namely launching an IPO, avail buyout offers from big technology entities and avail buyout offers from financial buyers.
days to go:
Expired
investment:
£525,500
Ancon is designed to detect trace elements of things such as explosives, drugs and chemical weapons in the air. Ancon manufactures equipment and components that are up to 10,000 times more sensitive then anything else on the market.
days to go:
Expired
investment:
£1,043,525
Iceni Labs is an innovative enterprise that develops and deploys cutting-edge technologies to build a safer and secure future. The company takes early-stage technology from the lab to the market by partnering with leading academics, researchers, and commercial experts. It has collaborated with the UK National Health Service’s (NHS) Royal Papworth Hospital to accelerate the development of a non-contact device, SafeScan, that monitors the breathing rate of an individual remotely. Iceni Labs also conducted a one-year clinical study of the device at Royal Papworth Hospital on a sample size of 400 patients. It has been awarded Innovate UK funding to build a prototype for monitoring care home residents. The company's goal is to become globally recognised as a catalyst for successful innovation.
days to go:
Expired
investment:
Withheld
TagDox allows the user to securely store private documents and filter them easily with the ability to add keywords. The system also allows the user to share and make the documents publically available and tagdox automatically suggests tags to improve usability.
days to go:
Expired
investment:
£20,025
Untied is a groundbreaking app that gathers information, claims costs and allowances, and prepares tax filings on the go. All of these can be sent to the tax authority from the application. The app connects across existing accounts, making tax sense of transactions and gives the assurance someone needs. Backed by Accenture's Fintech Innovation Lab and Barclays Techstars, the company became the first overseas winner of Israel's biggest fintech prize at Fintech Junction. The business will earn a turn over of £100m in ten years making it ready for an IPO. With the proceeds, it will create new software platforms, publishers, banks, and accounting firms.
days to go:
Expired
investment:
£350,000
Beacon is a company that offers software and supporting services to help a client optimise their digital marketing efforts and improve their marketing Return-on-Investment (ROI). The company offers clients services like campaign management, PPC (Pay Per Click) campaign analytics, social media analytics, and anti-fraudulent click system etc. Using the company's portal, marketers can compare costs and revenue across all digital channels, channel by channel, and with their off-line marketing efforts. Beacon aims at removing ‘non-human clicks’ and giving direct independent attribution of emails, posts, ad’s, etc. to specific website actions and business goals thereby improving engagement and reducing costs. According to Stratistics Market Research Consulting, the web analytics tools market is expected to reach $4.9 billion by 2022, growing at a Compound Annual Growth Rate (CAGR) of 20.8%, in which, Beacon aims to be a leading contender. The company will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£240,000
On NightZookeeper.com, children create their magical animals that come to life (e.g. Tamagotchis), which teachers then use to deliver interactive lesson content. The children’s work is then sent to a teacher dashboard and automatically assessed. As well as building brand awareness and reach, the website has generated £100,000 in recurring annual subscriptions during the past 12 months.
days to go:
Expired
investment:
£585,368
Edozo goal is to transform data storage, data sharing and workflow efficiency for commercial property professionals.
days to go:
Expired
investment:
£350,000
Zentraxa is focused on precision bioengineering to produce peptides with predictable properties tailored towards purpose. The company points out that peptides are amino acids that are the building blocks of certain proteins needed by the skin, like collagen and elastin. It has come out with a synthetic biology platform, Zentide, that designs, produces and tests novel peptides. Zentraxa argues that Zentide can circumvent previously existing bio-design limits imposed by conventional peptide synthesis and produce tailor-made biomaterials for healthcare, personal care and industrial uses. Zentraxa is initially targeting healthcare with its first biomaterial, a debondable adhesive, for use in wound care. The company asserts that the material has other uses such as cosmetics and industrial applications due to its ability to bond strongly while still being easily and painlessly removable. Zentraxa will use the investment to create a portfolio of other biomaterials for licensing to global businesses in the health and industrial sectors via its Zentide platform.
days to go:
Expired
investment:
£1,040,000
